Chemomab Therapeutics (CMMB) Exchange Rate Effect (2018 - 2019)
Chemomab Therapeutics (CMMB) posted Exchange Rate Effect of $25000.0 for Q3 2019, down 83.55% on a QoQ basis from $152000.0 in Q4 2018, and up 125.0% year-over-year from $11111.1 in Q3 2018.
Chemomab Therapeutics (CMMB) Exchange Rate Effect (2018 - 2019) Analysis & Trends
Chemomab Therapeutics' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $25000.0 for Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Chemomab Therapeutics | 704.11 Mn | 693.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 25,000.00 |
| Sep 30, 2019 | 25,000.00 |
| Dec 31, 2018 | 152,000.00 |
| Dec 31, 2018 | 152,000.00 |
| Sep 30, 2018 | -100,000.00 |
| Sep 30, 2018 | -100,000.00 |